Logo
Nazad
C. Ay, I. Pabinger, Katarina D Kovacevic, Georg Gelbenegger, C. Schoergenhofer, P. Quehenberger, P. Jilma-Stohlawetz, R. Sunder-Plassmann, J. Gilbert, Shuhao Zhu, B. Jilma, U. Derhaschnig
10 30. 6. 2022.

The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease

Key Points The aptamer rondoraptivon pegol improved VWF/FVIII levels, multimer patterns, and thrombocytopenia in type 2B von Willebrand disease. Once weekly subcutaneous injections of rondoraptivon pegol may in the future be used for prophylaxis or treatment of VWD.


Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više